1. Market Research
  2. > Pharmaceutical Market Trends

Animal Pharm Veterinary Parasites and Antiparasitics in Latin America 2016

  • January 2016
  • 128 pages
  • Animal Pharm
Report ID: 3707632


Table of Contents

Search Inside


In Latin America, as elsewhere in the world, Gastrointestinal Nematodes (GINs) are the most important parasites for all kinds of livestock and pets. Ticks and several fly species are very harmful for ruminants as well. Fleas and ticks are the most relevant external parasites of dogs and cats. A few important parasite species are endemic in Latin America, e.g. human bot flies (Dermatobia hominis) and screwworms (Cochliomyia hominivorax). Other parasites that are important elsewhere are not an issue in Latin America, e.g. sheep blowflies, cattle grubs or cattle face flies. Currently, most of these parasites can be reasonable controlled with the available antiparasitics but resistance problems are becoming dramatic in several parasite groups such as GINs (mainly in sheep, goats, cattle and horses), as well as cattle ticks (Rhipicephalus microplus) and horn flies (Haematobia irritans) in cattle. Resistance is likely to become a major challenge in the next decades but will also bear opportunities for novel active ingredients with a new mechanism of action.Cattle dominate the livestock market in Latin America.

There are more cattle in Latin America than sheep, goats, horses, pigs, dogs and cats together. In 2013, Latin America produced almost as much beef as the USA and the EU together. For this reason, cattle products dominate the Latin American animal health market, also in antiparasitics. Brazil dominates Latin America, with more than 50% of the cattle population. The Latin American antiparasitics market was estimated to be close to US$ 900 million in 2014, with cattle making up to 55% of the total value, and pets less than 15%. It is highly fragmented, with hundreds of domestic companies selling thousands of antiparasitic products. And it is a generics market. Out of more than 2,600 antiparasitic products there is currently only one livestock product (Zolvix) containing a patent protected active ingredient (monepantel), and 4 dog products whose active ingredients are still patent protected (afoxolaner, fluralaner, pyriprole, indoxacarb). Macrocyclic lactones (MLs) are the dominant chemical class of antiparasitics, with more than 700 different products. There are hundreds of clones of the mythical 1% ivermectin injectable (Ivomec), and dozens of combinations with other antiparasitics or with vitamins, aminoacids, minerals, growth promoters, etc. Some domestic companies offer a full range of MLs for livestock including products with all the available compounds: abamectin, doramectin, eprinomectin, ivermectin and moxidectin. Benzimidazoles and Synthetic Pyrethroids are the second and third most used chemical classes of antiparasitics.

Besides the usual global multinationals – Bayer, Elanco, Merial, MSD Animal Health, Virbac, Zoetis – about 25 other domestic companies market their own antiparasitics portfolio of 20 or more different products in Latin America. In fact, the companies with the largest antiparasitics portfolios are domestic companies, not global multinationals, although this does not mean that they achieve higher or even comparable sales. In addition, more than 80 other domestic companies market between 10 and 20 antiparasitic products each. Many of these domestic companies are very creative and have introduced not only generic clones of the classic original products but also numerous innovative formulations with the active ingredients that have lost patent protection in the last decades.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Ahmad helps you find the right report:


The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

OpportunityAnalyzer: Cystic Fibrosis - Opportunity Analysis and Forecasts to 2025

  • $ 10995
  • Industry report
  • April 2017
  • by GlobalData

OpportunityAnalyzer: Cystic Fibrosis - Opportunity Analysis and Forecasts to 2025 Summary Cystic fibrosis (CF), which has been given a the diagnostic code E84 from The International Classification of Diseases, ...

High Content Screening Market by Product (Cell Imaging & Analysis System, Flow Cytometry, Consumable, Software, Service) Application (Primary & Secondary Screening, Toxicity Studies, Target Identification & Validation), End User - Global Forecast to 2022

  • $ 5650
  • Industry report
  • April 2017
  • by MarketsandMarkets

The global high-content screening (HCS) market is projected to reach USD 909.0 million by 2022 at a CAGR of 10.3% during the forecast period. The factors expected to drive the growth of the market are ...

Pharmaceutical Filtration Market by Product (Membrane Filters, Single-Use Systems), Technique (Microfiltration, Ultrafiltration), Application (Final Product Processing, Raw material), Scale of Operation (Manufacturing, Pilot, R&D) - Global Forecast to 202

  • $ 5650
  • Industry report
  • March 2017
  • by MarketsandMarkets

The global pharmaceutical filtration market is projected to reach USD 22.71 billion by 2021 from USD 13.73 billion in 2016, at a CAGR of 10.6% from 2016 to 2021. Market growth is primarily driven by factors ...

Social Media In Pharma

March 2017 $ 5000


Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.